California Moves to Ban High-Silica Engineered Stone Countertops to Protect Workers
Cal/OSHA issued draft rules to prohibit the fabrication of artificial stone products containing more than 1% crystalline silica, citing lung risks to workers.
Category: Other Chronic Diseases
Other Chronic Diseases
Latest
California Moves to Ban High-Silica Engineered Stone Countertops to Protect Workers
Cal/OSHA issued draft rules to prohibit the fabrication of artificial stone products containing more than 1% crystalline silica, citing lung risks to workers.
Read More
Military Blast Exposure Tied to Respiratory, Neurological Conditions
Veterans exposed to high-level explosive blasts face higher rates of emphysema, chronic bronchitis, and stroke years after service.
Read More
Salt Aerosol May Counter Increased Cough Sensitivity from Dry Air
Exposure to very dry air collapses airway mucus, but an inhaled magnesium mist could help protect the respiratory tract.
Read More
FDA Grants Priority Review for Arikayce Inhaled Antibiotic for MAC
The FDA accepted Insmed’s supplemental new drug application with Priority Review for Arikayce to treat Mycobacterium avium complex (MAC) lung disease.
Read More
Genetic Discovery for Primary Ciliary Dyskinesia
Researchers identified genetic-related structural defects that prevent cilia from clearing mucus in primary ciliary dyskinesia patients.
Read More
High-dose Flu Vaccine Cuts Senior Hospitalizations
A high-dose vaccine reduced hospital admissions for flu or pneumonia by nearly 9% among older individuals with chronic respiratory conditions like asthma and COPD.
Read More
WHO Expanding Child Access to Sickle Cell Treatments
New global guidance and manufacturing initiatives focus on delivering age-appropriate sickle cell therapies to pediatric patients.
Read More
Brinsupri/Brensocatib Approved for Bronchiectasis in Japan
Japan’s Ministry of Health, Labour and Welfare (MHLW) has approved Brinsupri (brensocatib 25-mg tablet), an oral, once-daily treatment for non-cystic fibrosis bronchiectasis (NCFB) in adults and pediatric patients 12 years and older, according to Insmed Inc.
Read More
Quartz Countertop Work Tied to Rise in Silicosis
A study of California workers identified nearly 600 cases of the incurable lung condition silicosis, prompting experts to call for national surveillance and stronger safety standards.
Read More
Study to Evaluate Effectiveness of Brensocatib for Bronchiectasis
The BEST-BE observational study will track 1,000 bronchiectasis patients to measure the impact of brensocatib on pulmonary exacerbations and patient quality of life.
Read More
Duchenne Muscular Dystrophy Cell Therapy Preserves Heart, Muscle Function
Results from the HOPE-3 trial found that an investigational cell therapy called deramiocel preserved heart and muscle function in boys and young men with Duchenne muscular dystrophy (DMD).
Read More
Diabetes Test May Misdiagnose Patients With Sickle Cell Trait
A standard laboratory assay significantly underestimates blood sugar levels in people with sickle cell trait, potentially leading to widespread underdiagnosis of diabetes.
Read More
Testosterone Treatment Linked to Reduced Inhaled Steroid Use
Men receiving systemic testosterone therapy showed a statistically significant decrease in inhaled corticosteroid use starting 18 to 24 months after treatment initiation.
Read More
CHLA Joins Sickle Cell Study on Gene Editing Method
Children’s Hospital Los Angeles joined a trial to investigate nula-cel, a gene-editing therapy designed to correct the sickle cell disease genetic mutation.
Read More
Predicting BPD in Preterm Infants via Machine Learning
Analyzing respiratory patterns through machine learning models improved early identification of bronchopulmonary dysplasia (BPD) in preterm infants.
Read More
Chronic Rhinosinusitis Balloon Begins Trial
A US study is evaluating a drug-coated balloon designed to improve outcomes for chronic rhinosinusitis patients undergoing sinus surgery.
Read More
First US Toddler Diagnosed With Rare Lung Disease
A two-year-old Indiana child is the first in the United States to be diagnosed with Rajab interstitial lung disease with brain calcifications, a rare genetic disease with only 10 known cases worldwide.
Read More
Last Polio Patient Using Iron Lung Passes Away in Oklahoma
Martha Lillard, who was diagnosed with polio at age 5, passed away at the age of 78 after using an iron lung device for over seven decades.
Read More
Alpha-1 Antitrypsin Deficiency Drug Enters Ph3 Trial
Grifols enrolled the first patient in its Phase 3 SWIFT-SC clinical trial to evaluate its subcutaneous Alpha1-Proteinase Inhibitor for the treatment of alpha1-antitrypsin (AAT) deficiency.
Read More
FDA Expands Casgevy for Children 2+ with Sickle Cell Disease
The FDA approved the first gene therapy for children as young as 2 years old with sickle cell disease or transfusion-dependent beta thalassemia.
Read More
3 Things to Know About Bronchiectasis
The American Lung Association launched an initiative to support people living with bronchiectasis through patient and provider resources.
Read More
Fifth Annual World Bronchiectasis Day Set for July 1
Global organizations unite to raise awareness and improve care for more than 1 million people living with bronchiectasis.
Read More
Global Respiratory Societies Mark World Bronchiectasis Day 2026
On July 1, international organizations aim to increase awareness and research for bronchiectasis to improve patient outcomes and healthcare access.
Read More
Comorbid Bronchiectasis + Diabetes Tied to Worse Outcomes
A large-scale international study found that comorbid bronchiectasis and diabetes is associated with higher mortality, increased hospitalizations, and more frequent exacerbations.
Read More